These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 7961010)

  • 1. Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer.
    Glicksman AS; Slotman G; Doolittle C; Clark J; Koness J; Coachman N; Posner M; DeRosa E; Wanebo H
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1043-50. PubMed ID: 7961010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.
    Wanebo HJ; Glicksman AS; Landman C; Slotman G; Doolittle C; Clark J; Koness RJ
    Am J Surg; 1995 Nov; 170(5):512-6. PubMed ID: 7485745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer.
    Glicksman AS; Wanebo HJ; Slotman G; Liu L; Landmann C; Clark J; Zhu TC; Lohri A; Probst R
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):721-9. PubMed ID: 9336155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative simultaneously administered cis-platinum plus radiation therapy for advanced squamous cell carcinoma of the head and neck.
    Slotman GJ; Cummings FJ; Glicksman AR; Doolittle CL; Leone LA
    Head Neck Surg; 1986; 8(3):159-64. PubMed ID: 3744847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
    Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
    Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
    J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism.
    Weisman RA; Christen R; Los G; Jones V; Kerber C; Seagren S; Glassmeyer S; Orloff LA; Wong W; Kirmani S; Howell S
    Otolaryngol Head Neck Surg; 1998 May; 118(5):597-602. PubMed ID: 9591856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results.
    Adelstein DJ; Saxton JP; Lavertu P; Tuason L; Wood BG; Wanamaker JR; Eliachar I; Strome M; Van Kirk MA
    Head Neck; 1997 Oct; 19(7):567-75. PubMed ID: 9323144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative combined chemotherapy and radiation therapy plus radical surgery in advanced head and neck cancer. Five-year results with impressive complete response rates and high survival.
    Slotman GJ; Doolittle CH; Glicksman AS
    Cancer; 1992 Jun; 69(11):2736-43. PubMed ID: 1571903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative chemotherapy-sensitized radiation therapy for cervical metastases in head and neck cancer.
    Puc MM; Chrzanowski FA; Tran HS; Liu L; Glicksman AS; Landman C; Slotman GJ
    Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):337-42. PubMed ID: 10722006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary site management following induction chemotherapy with cis-platinum, 5-fluorouracil, and leucovorin.
    Busse PM; Clark JR; Beard CJ; Dreyfuss AI; Lucarini JW; Rossi R; Casey D; Norris CM
    Head Neck; 1993; 15(5):413-8. PubMed ID: 8407313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.
    Cooper JS; Pajak TF; Forastiere AA; Jacobs J; Campbell BH; Saxman SB; Kish JA; Kim HE; Cmelak AJ; Rotman M; Machtay M; Ensley JF; Chao KS; Schultz CJ; Lee N; Fu KK;
    N Engl J Med; 2004 May; 350(19):1937-44. PubMed ID: 15128893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.
    Bernier J; Domenge C; Ozsahin M; Matuszewska K; Lefèbvre JL; Greiner RH; Giralt J; Maingon P; Rolland F; Bolla M; Cognetti F; Bourhis J; Kirkpatrick A; van Glabbeke M;
    N Engl J Med; 2004 May; 350(19):1945-52. PubMed ID: 15128894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol.
    Abitbol A; Abdel-Wahab M; Lewin A; Troner M; Rodrigues MA; Hamilton-Nelson KL; Markoe A
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):942-7. PubMed ID: 12095561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent chemoradiotherapy with low-dose cisplatin plus 5-fluorouracil for the treatment of patients with unresectable head and neck cancer.
    Kohno N; Kitahara S; Tamura E; Tanabe T
    Oncology; 2002; 63(3):226-31. PubMed ID: 12381901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence patterns with concurrent platinum-based chemotherapy and accelerated hyperfractionated radiotherapy in stage III and IV head and neck cancer patients.
    Koness RJ; Glicksman A; Liu L; Coachman N; Landman C; Slotman G; Wanebo HJ
    Am J Surg; 1997 Nov; 174(5):532-5. PubMed ID: 9374231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma.
    Urba SG; Forastiere AA; Wolf GT; Esclamado RM; McLaughlin PW; Thornton AF
    J Clin Oncol; 1994 May; 12(5):946-53. PubMed ID: 8164046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24.
    Al-Sarraf M; Pajak TF; Byhardt RW; Beitler JJ; Salter MM; Cooper JS
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):777-82. PubMed ID: 9128951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
    Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.